1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Circassia Ltd

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2006

Location

Oxford UK

Primary Industry

Pharmaceuticals

About

Circassia Limited is a specialty biopharmaceutical company, focused on developing immunotherapies to treat allergies, prevent organ transplant rejection and improve recovery from surgeries.
Current Investors
Invesco Perpetual, Touchstone Innovations, Lansdowne Partners

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.circassia.co.uk
Company Stage
Mature
Total Amount Raised
Subscriber access only

Timeline of Key Events

TimeLine Events

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Employee Data

Employee Graph

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.